InsiderBoltOpen live tracker
Home › Stocks › SYRE insider trading

SYRE insider trading — Spyre Therapeutics, Inc.

No open-market insider purchases or sales were filed for Spyre Therapeutics, Inc. (SYRE) in the last 90 days. Other insider transactions — such as stock awards, option exercises or tax withholding — are listed below.

Updated Oct 16, 2026.

Insider buying · 90d
$0
Insider selling · 90d
$0
Net · 90d
$0
Last 30 days
0B / 0S

Scan SYRE live in the tracker

Recent SYRE insider transactions

Every Form 4 filed by Spyre Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.

Trade dateInsiderRoleTypeOwnershipSharesPriceValueFiling
Oct 1, 2026King-Jones HeidySee RemarksM · Option exercise · 10b5-1Direct28,933$14.50$420KForm 4
Oct 1, 2026King-Jones HeidySee RemarksS · Sale · 10b5-1Direct28,933$91.03$2.63MForm 4
Oct 1, 2026Burrows Scott LChief Financial OfficerM · Option exercise · 10b5-1Direct7,500$14.50$109KForm 4
Oct 1, 2026Burrows Scott LChief Financial OfficerS · Sale · 10b5-1Direct7,500$91.83$689KForm 4
Oct 1, 2026Turtle CameronChief Executive OfficerS · Sale · 10b5-1Direct15,000$92.01$1.38MForm 4
Sep 30, 2026Burrows Scott LChief Financial OfficerM · Option exercise · 10b5-1Direct17,500$14.50$254KForm 4
Sep 30, 2026Burrows Scott LChief Financial OfficerS · Sale · 10b5-1Direct17,500$89.89$1.57MForm 4
Sep 2, 2026King-Jones HeidySee RemarksM · Option exercise · 10b5-1Direct400$14.50$6KForm 4
Sep 2, 2026King-Jones HeidySee RemarksS · Sale · 10b5-1Direct400$90.00$36KForm 4
Sep 1, 2026King-Jones HeidySee RemarksM · Option exercise · 10b5-1Direct27,999$14.50$406KForm 4
Sep 1, 2026King-Jones HeidySee RemarksS · Sale · 10b5-1Direct27,999$87.31$2.44MForm 4
Sep 2, 2026Burrows Scott LChief Financial OfficerS · Sale · 10b5-1Direct18,232$89.35$1.63MForm 4
Sep 1, 2026Burrows Scott LChief Financial OfficerM · Option exercise · 10b5-1Direct7,500$14.50$109KForm 4
Sep 1, 2026Burrows Scott LChief Financial OfficerS · Sale · 10b5-1Direct7,500$87.31$655KForm 4
Sep 1, 2026Turtle CameronChief Executive OfficerS · Sale · 10b5-1Direct15,000$87.29$1.31MForm 4
Aug 7, 2026Albers Jeffrey W.DirectorM · Option exercise · 10b5-1Direct5,000$10.39$52KForm 4
Aug 7, 2026Albers Jeffrey W.DirectorS · Sale · 10b5-1Direct5,000$104.47$522KForm 4
Aug 7, 2026Albers Jeffrey W.DirectorS · Sale · 10b5-1Indirect18,000$104.55$1.88MForm 4
Aug 3, 2026Burrows Scott LChief Financial OfficerM · Option exercise · 10b5-1Direct7,500$14.50$109KForm 4
Aug 3, 2026Burrows Scott LChief Financial OfficerS · Sale · 10b5-1Direct7,500$95.57$717KForm 4
Aug 3, 2026Turtle CameronChief Executive OfficerS · Sale · 10b5-1Direct15,000$95.51$1.43MForm 4

SYRE insider trading FAQ

Are insiders buying SYRE stock?

Not on the open market. In the last 90 days, Spyre Therapeutics, Inc. insiders made no open-market purchases, and no open-market sales. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).

Who are the insiders trading SYRE?

No insider bought or sold on the open market in the last 90 days.

Where does SYRE insider trading data come from?

Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.

More stocks with insider activity

NYAXNayax Ltd.KBDCKayne Anderson BDC, Inc.GMEGameStop Corp.GSATGlobalstar, Inc.BCBPBCB Bancorp IncFULFuller H B CoBWMXBetterware de Mexico, S.A.P.I. de C.VFGBIFirst Guaranty Bancshares, Inc.BORRBorr Drilling LtdAGMBAgomAb Therapeutics NVHHHHoward Hughes Holdings Inc.CVCapsoVision, Inc

Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.